Latest Articles

Scientists have demonstrated the potential for using intratumoral microdevices (IMDs) to test various cancer drugs on the tumor before implementing systemic treatment. The approach could offer a hope in tackling hard-to-treat gliomas.

Biopharmaceuticals require careful analysis during research, development and manufacturing. In this article, we highlight some of the analytical techniques employed in biopharmaceutical analysis, and how the field is evolving to meet new challenges.

Ketamine is increasingly used as an antidepressant. A new clinical trial suggests the drug's effects may be may be placebo-based. In this article, we explore what that means for the drug's rollout for ketamine and psychedelic research.

This article explores the current state of drug monitoring and highlights the important role precision dosing can play in optimizing patient care.

Professor Donald Ingber is responsible for developing human organ chips, which provide researchers with a window into inter-organ physiology and the body’s response to drugs, without animal testing. Technology Networks' invited Ingber to an Ask Me Anything session to answer your questions about this incredible technology.

Capillary electrophoresis is a powerful separation and analysis technique that offers quick and efficient results. In this article, we explore how it works, variations on the technique and their applications.

By decoding the biological lexicon and integrating diverse forms of data, AI offers new possibilities for modeling biology and designing therapies. In this article, we explore the potential of recent advancements in AI to revolutionize drug R&D.

A recent study found that over one-third of men aged 15 years and over are infected with at least one type of HPV. In this article, we explore why HPV is not just a women's health issue.

In this article, we consider various platforms to modulate gene expression and the potential of CRISPR-Cas systems to understand and treat diseases, from cancers and congenital disorders to overcoming the growing prevalence of antimicrobial resistance.

This article explores why the traditional process of sorting through RWD is a challenge, what value is lost through that process, and the underlying technology needed to be able to filter and sort data in a compliant manner.